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Abstract
Purpose:  To  determine  the  likelihood  that  clinicians  know  carbon  dioxide  levels  before  adminis-
tering supplemental  oxygen  to  patients  with  neuromuscular  disorders,  to  quantitate  the  effect
of oxygen  therapy  on  carbon  dioxide  retention,  and  to  explore  hypercapnia  contributing  to  the
need to  intubate  and  use  of  continuous  noninvasive  ventilatory  support  to  avert  it.
Basic procedures:  A  retrospective  chart  review  for  patients  with  neuromuscular  disorders  intu-
bated or  having  intubation  averted  by  using  continuous  noninvasive  ventilatory  support  with
carbon dioxide  known  pre-  and  during  oxygen  administration.
Main ﬁndings:  For  only  2  of  316  patients  who  were  intubated  did  clinicians  know  carbon  diox-
ide levels  prior  to  administering  oxygen.  For  four  cases,  intubation  was  averted  by  continuous
noninvasive  ventilatory  support  and  mechanical  insufﬂation--exsufﬂation  despite  severe  hyper-
capnia and  acidosis.  After  initiating  oxygen  therapy,  patients’  carbon  dioxide  partial  pressures
increased  52.1  ±  42.0  mm  Hg  in  over  as  little  as  20  min.
Principal  conclusions:  Clinicians  should  attempt  to  use  continuous  noninvasive  ventilatory  sup-
port and  mechanical  insufﬂation--exsufﬂation  rather  than  supplemental  oxygen  to  normalize
blood gases  for  neuromuscular  ventilatory  failure  and  should  be  prepared  to  intubate  hyper-
capnic patients  for  whom  oxygen  is  administered.
© 2016  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Abbreviations: ABG, arterial blood gas; CMV, continuous mandatory ventilation; CNVS, continuous noninvasive ventilatory support; CO2,
arbon dioxide; CTMV, continuous tracheostomy mechanical ventilation; EPAP, expiratory positive airway pressure; EtCO2, end-tidal carbon
ioxide; FEV1, forced expiratory volume-one second; FiO2, fraction of inspired oxygen; ICU, intensive care unit; IPAP, inspiratory positive
irway pressure; MIE, mechanical insufﬂation--exsufﬂation; NMD, neuromuscular disease; NVS, noninvasive ventilatory support; O2, oxygen;
2 sat, oxyhemoglobin saturation; PaCO2, partial pressure of carbon dio
lood; PAP, positive airway pressure; SMA, spinal muscular atrophy; UR
olume.
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ttp://dx.doi.org/10.1016/j.rppnen.2016.03.005
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Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)xide in arterial blood; PaO2, partial pressure of oxygen in arterial
I, upper respiratory tract infection; VC, vital capacity; Vt, tidal
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Introduction
Although  administering  supplemental  oxygen  (O2)  to  hyper-
capnic  patients  with  cardiopulmonary  disease  can  decrease
dyspnea,  pulmonary  hypertension,  polycythemia,  exercise
intolerance,  permit  greater  ventilator-free  breathing  partic-
ularly  for  chronic  lung  disease  patients,  and  prolong  life,1--5
it  can  also  depress  hypoxic  ventilatory  drive  and  exacer-
bate  hypercapnia.2,3 With  the  advancing  respiratory  muscle
weakness  of  patients  with  neuromuscular  disease  (NMD),
however,  it  can  render  noninvasive  ventilation  ineffective,6
which  can  cause  carbon  dioxide  (CO2)  narcosis,  coma,  and
acute  on  chronic  respiratory  failure.
In  intensive  care  units  (ICUs),  since  it  is  far  more  com-
mon  to  encounter  patients  with  lung  disease  than  NMDs,  it
is  generally  assumed  that  O2 administration  is  harmless  for
anyone  with  respiratory  symptoms  and  that  NMD  patients
must  accommodate  elevated  baseline  CO2 levels  anyway  so
emergency  services  tend  to  administer  O2 immediately  to
all  such  symptomatic  patients  without  ﬁrst  determining  CO2
levels.7 The  only  publication  that  has  thus  far  quantitated
O2-induced  hypercapnia  in  NMD  is  that  of  Gay  and  Edmonds
in  1995,8 and  they  could  only  identify  the  pre-  and  post-
O2 delivery  CO2 levels  for  eight  patients  including  three
with  polymyositis,  three  with  motor  neuron  disease,  and
one  each  with  inﬂammatory  motor  neuropathy  and  chronic
poliomyelitis.  The  patients  received  low-ﬂow  O2 and  within
0.8--144  h,  three  became  obtunded  and  required  intubation
but  subsequently  recovered;  and  two  died  when  intubation
was  declined.  Neither  noninvasive  ventilatory  support  (NVS)
nor  mechanical  insufﬂation--exsufﬂation  (MIE)  was  used  to
either  avoid  intubation  or  facilitate  successful  extubation.
Bi-level  positive  airway  pressure  (PAP)  is  generally  used
in  acute  and  chronic  care  at  less  than  full  ventilatory  sup-
port  settings.  However,  many  patients  with  little  or  no  vital
capacity  (VC)  require  continuous  NVS  (CNVS)  at  volume  or
pressure  settings  that  fully  support  respiratory  muscle  func-
tion.  Two  studies  reported  166  patients  with  respiratory
pump  failure  who  required  intubation  after  having  been
administered  O2 supplementation.9,10 Another  61  patients
underwent  tracheotomy  after  being  intubated  following  O2
administration  for  acute  on  chronic  respiratory  failure.11
None  of  these  227  patients  had  been  offered  CNVS  or  MIE10
to  either  prevent  intubation  or  facilitate  extubation  prior  to
transfer  to  a  specialized  unit  for  extubation  or  decanulation
to  CNVS  and  MIE.  The  purpose  of  this  case  series  is  to  deter-
mine  the  likelihood  that  clinicians  obtain  CO2 levels  before
administering  O2 to  patients  with  NMD,  to  quantitate  sub-
sequent  CO2 levels  as  a  contributing  factor  in  the  need  to
intubate,  and  to  describe  the  use  of  CNVS  and  MIE  to  reverse
hypercapnia  and  avert  invasive  airway  intubation.
Methods
Consecutive  outpatients  to  a  NMD  clinic  from  1996  to  2015
were  screened  for  having  received  O2 therapy,  undergoing
intubation  then  possibly  tracheotomy,  then  being  extubated
or  decanulated  to  CNVS  and  MIE.  In  addition,  we  screened
for  others  whose  hypercapnia  had  been  documented  either
by  arterial  blood  gas  sampling  or  by  end-tidal  CO2 (EtCO2)
measurements  before  O2 therapy  but  who  were  spared  intu-
bation  by  using  CNVS  and  MIE.  The  MIE  was  administered
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y  both  hospital  staff  via  invasive  airway  tubes  and  by
he  patients’  relatives  post-extubation/decanulation  in  the
cute  care  setting  up  to  every  20--30  min  during  waking
ours  via  oronasal  interfaces  at  insufﬂation  and  exsufﬂation
ressures  of  50--60  cm  H2O  until  ambient  air  oxyhemoglobin
aturation  (O2 sat)  baseline  remained  greater  than  94%.
esults
f  2804  patients  with  NMD,  316  were  identiﬁed  who  had
ndergone  intubation,  then  61  of  316  tracheotomy.  All  were
ubsequently  extubated  or  decanulated  to  CNVS  and  MIE.9--11
f  these,  only  nine  cases  had  had  CO2 levels  available  both
re-  and  during  O2 administration,  and  for  only  cases  1  and
 was  the  CO2 known  by  the  clinicians  who  administered
he  O2 and  intubated  the  patients.  For  cases  2,  3,  7,  and  9
hose  hypercapnia  worsened  during  O2 therapy,  intubation
as  averted  by  using  CNVS  and  MIE.
ase  presentations
ase  1:  A  27-year-old  woman  with  nemaline  rod  myopathy
ad  failed  extubation  following  scoliosis  surgery  at  age  10,
ut  she  was  successfully  extubated  to  CNVS  and  MIE  upon
ransfer  to  our  intensive  care  unit  (ICU).9,10 From  age  10
o  27,  she  used  bi-level  PAP  at  an  inspiratory  (I)PAP  of  18  cm
2O,  expiratory  (E)PAP  of  4  cm  H2O,  and  rate  13  breaths/min
nly  during  intercurrent  upper  respiratory  tract  infections
URI)  despite  having  a  VC  as  low  as  340  mL.  In  Decem-
er  2014,  she  presented  to  emergency  services  with  a  URI
nd  partial  pressure  of  CO2 in  arterial  blood  (PaCO2)  of
7  mm  Hg  despite  continuous  use  of  bi-level  PAP.  Then,  she
as  started  on  supplemental  O2.  Over  a  2-h  period,  her
aCO2 increased  to  67  mm  Hg.  She  became  obtunded,  was
ntubated,  and  failed  one  extubation  attempt  to  IPAP  8  cm
2O,  EPAP  4  cm  H2O,  and  supplemental  O2.  After  nine  total
ays  of  intubation,  she  was  transferred  to  our  ICU,  where
he  was  successfully  extubated  to  CNVS  and  MIE.  Her  PaCO2
emained  below  40  mm  Hg,  and  she  was  discharged  home  4
ays  later,  where  she  eventually  weaned  to  nocturnal  nasal
VS.
Case  2:  A  32-year-old  wheelchair-dependent  man  with
ecker  muscular  dystrophy  began  to  use  nocturnal  nasal  NVS
n  November  2013  to  treat  fatigue,  sleepiness,  difﬁculty  con-
entrating,  and  hypercapnia.  He  had  a  VC  of  550  mL  and  an
tCO2 of  77  mm  Hg.  His  symptoms  cleared  and  diurnal  EtCO2
ecreased  to  54  mm  Hg,  but  since  he  refused  to  use  NVS  dur-
ng  daytime  hours,  he  again  developed  mild  confusion  and
resented  to  emergency  services  in  February  2014.  He  was
laced  on  100%  fraction  of  inspired  O2 (FiO2) and  became
btunded  over  the  next  20  min.  An  arterial  blood  gas  (ABG)
evealed  a  PaCO2 of  177  mm  Hg,  bicarbonate  of  41  meq/L,
nd  pH  of  6.98.  The  patient  was  manually  resuscitated
nd  immediate  intubation  was  recommended.  However,  the
ather  insisted  that  the  author  (Bach)  be  called  ﬁrst,  and
hen  it  was  discovered  that  the  patient’s  portable  ventila-
or  was  in  the  trunk  of  his  car,  the  father  retrieved  it  and
dministered  nasal  CNVS  at  a  volume-preset  of  1150  mL  and
ate  12  breaths/min.  A  few  minutes  later,  the  patient  transi-
ioned  to  mouthpiece  CNVS  and,  20  min  later,  was  discharged
ome  with  normal  O2 sat,  fully  coherent,  and  in  no  distress.
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t  his  next  outpatient  visit  in  May  2014,  now  using  CNVS,
he  patient’s  EtCO2 remained  below  40  mm  Hg  and  ambient
ir  O2 sat  was  normal.  When  breathing  unassisted  for  a  few
inutes,  his  EtCO2 increased  to  46  mm  Hg.
Case  3:  A 15-year-old  boy  with  spinal  muscular  atro-
hy  type  1  (SMA),  who  was  CNVS-dependent  with  a  VC
f  10  mL  and  received  all  nutrition  via  a  nasogastric  tube
ince  8  months  of  age,  was  admitted  to  a  pediatric  ICU
or  respiratory  distress  despite  pressure-controlled  con-
inuous  mandatory  ventilation  (CMV)  at  24  cm  H2O,  rate
2  breaths/min.  At  5  PM,  his  PaCO2 was  21  mm  Hg  and  partial
ressure  of  O2 in  arterial  blood  (PaO2)  of  42  mm  Hg.  He  was
laced  on  FiO2 of  32%  along  with  CNVS.  Thirteen  hours  later,
is  PaCO2 increased  to  56  mm  Hg  with  a PaO2 of  59  mm  Hg.
s  his  aspiration  pneumonitis  resolved,  his  FiO2 was  reduced
o  28%.  Two  hours  later,  his  PaCO2 decreased  to  49  mm  Hg.
e  was  discharged  home  with  normal  O2 sat  and  EtCO2 of
5  mm  Hg.  At  a  2-week  follow-up  outpatient  visit,  his  EtCO2
as  30  mm  Hg,  which  had  been  his  baseline.
Case  4:  A  4-year-old  boy  with  SMA2,  baseline  VC  of
80  mL,  and  EtCO2 of  46  mm  Hg  was  admitted  to  a  pediatric
CU  for  distress  due  to  a  URI.  He  was  using  volume-
reset  CMV  at  750  mL,  rate  16  breaths/min.  His  PaCO2 was
1  mm  Hg.  He  was  placed  on  FiO2 of  50%  and  became  disori-
nted  over  the  next  2  h.  A  repeat  ABG  drawn  on  FiO2 of  40%
howed  a  PaCO2 of  73  mm  Hg  and  PaO2 of  67  mm  Hg.  He  was
hen  intubated  and  his  PaCO2 normalized.  Two  days  later,
n  FiO2 of  21%,  he  was  extubated  back  to  CNVS  on  CMV  at
0  cm  H2O,  rate  16  breaths/min.
Case  5:  A  60-year-old  woman  with  facioscapulohumeral
uscular  dystrophy  using  nocturnal  CMV  (Vt  1000  mL,  rate
2  breaths/min,  FiO2 21%)  had  a  VC  of  640  mL  (sitting)  and
80  mL  (supine)  and  EtCO2 of  39  mm  Hg.  On  a  routine  visit
o  her  pulmonologist,  despite  normal  pulse  oximetry,  she
as  placed  on  2  L/min  O2 and  bronchodilators.  Three  weeks
ater,  she  was  admitted  for  CO2 narcosis,  intubated,  and
nderwent  tracheotomy.  She  used  continuous  tracheostomy
echanical  ventilation  (CTMV)  for  4  months  until  she  was
ecanulated  to  CNVS  on  her  previous  settings.  Her  EtCO2
emained  32--40  mm  Hg  using  CNVS  over  the  next  six  outpa-
ient  visits  spanning  5  years  despite  her  VC  decreasing  to
50  mL.
Case  6:  A  7-year-old  boy  with  SMA1  and  CNVS  dependence
ince  4  months  of  age,  who  had  an  EtCO2 of  19--34  mm  Hg
ver  11  outpatient  visits  and  a  VC  of  15  mL,  was  hospitalized
or  gastroenteritis.  Although  he  had  no  respiratory  symp-
oms,  he  was  placed  on  FiO2 of  50%.  Eleven  hours  later,  on
epeat  ABG,  his  PaCO2 had  increased  from  43  on  admission
o  62  mm  Hg  with  a  PaO2 of  48  mm  Hg,  and  he  was  intubated
or  3  days.  Once  stabilized  with  normal  O2 sat  and  CO2 on
mbient  air,  he  was  extubated  back  to  CNVS  and  discharged
ome  5  days  later.
Case  7:  A  32-year-old  man  with  myotonic  dystrophy  using
NVS  was  admitted  for  aspiration  pneumonia.  On  admis-
ion,  with  a  PaCO2 of  40  mm  Hg  and  PaO2 of  79  mm  Hg,  he
as  placed  on  FiO2 of  32%.  Three  days  later,  his  PaCO2 was
8  mm  Hg  with  PaO2 53  mm  Hg.  Then,  O2 was  discontinued
nd  the  PaCO2 normalized  to  39  mm  Hg.  Three  days  later,  he
as  discharged  home  using  nocturnal-only  nasal  NVS.
Case  8:  A  71-year-old  woman  with  post-poliomyelitis  ven-
ilatory  insufﬁciency,  baseline  VC  of  500  mL,  and  EtCO2
5  mm  Hg  was  placed  on  2  L/min  O2 to  treat  exertional
v
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yspnea.  Six  weeks  later,  she  was  hospitalized  for  CO2
arcosis  with  a  PaCO2 of  106  mm  Hg.  She  was  intubated,
ailed  conventional  weaning/extubation,  and  transferred
or  extubation  to  CNVS  and  MIE.9,10 Three  days  later,  she
as  discharged  home  using  sleep  NVS  on  CMV  at  Vt  950  mL,
ate  12  breaths/min.  At  a  3-day  follow-up,  her  EtCO2 was
0  mm  Hg  with  normal  O2 sat.
Case  9:  A  12-month-old  CNVS  dependent  infant  with  SMA
ype  1  used  nasal  CNVS  at  20  cm  pressure  and  her  PaCO2
anged  from  37  to  43  mm  Hg  over  a  5-day  period.  Venti-
ator  weaning  was  attempted,  but  her  PaCO2 increased  to
9  mm  Hg  and  O2 sat  decreased  at  which  point  she  was
laced  back  on  CNVS  with  low-ﬂow  O2. Three  hours  later,
er  PaCO2 was  168  mm  Hg.  Intubation  was  averted  by  dis-
ontinuing  the  O2,  and  use  of  CNVS  quickly  normalized  her
O2 level  to  36  mm  Hg.
iscussion
onsistent  with  the  report  of  Gay  and  Edmonds,8 who  found
 mean  increase  in  CO2 of  28.2  ±  23.3  mm  Hg  with  O2 therapy
or  eight  patients  with  NMD,  the  CO2 of  our  cases  increased
rom  43.8  to  95.9  mm  Hg  or  52.1  ±  42.0  mm  Hg  (range  of
1--59  to  56--177)  over  a  mean  17.4  h  (range  of  20  min  to  6
eeks).  Whereas  Gay  and  Edmonds  did  not  use  NVS  or  MIE,
ur  cases  2,  3,  7,  and  9  avoided  intubation  because  of  it.
Case  1  became  hypercapnic  because  bi-level  PAP  settings
ere  inadequate  to  fully  rest  or  support  a  patient  with  little
C.  Normally  compliant  lungs  require  full  tidal  volumes  or
ressure  settings  of  18--20  cm  H2O.  While  O2 therapy  exacer-
ates  hypercapnia  by  suppressing  hypoxic  drive  for  patients
reathing  spontaneously,  for  nasal  bi-level  PAP  or  NVS  users
ike  cases  1,  3,  6,  and  9,  it  resulted  in  increased  ventila-
ion  leakage  out  of  the  mouth.6 Patients  with  little  or  no  VC
an  maintain  normal  lung  ventilation  during  sleep  by  using
pen  systems  of  NVS  provided  that  ventilatory  drive  is  ade-
uate  to  reﬂexively  prevent  excessive  air  leakage  to  avoid
evere  hypercapnia.  This  reﬂex  activity  occurs  at  the  nadir
f  O2 desaturations  and  is  suppressed  by  O2 administration.6
ther  mechanisms  for  O2-exacerbated  hypercapnia  include
orsening  ventilation-perfusion  matching  secondary  to
ttenuation  of  hypoxic  pulmonary  vasoconstriction,  depres-
ion  of  diaphragm  function,9 and  decreased  afﬁnity  of
emoglobin  for  CO2 (Haldane  effect),  which  results  in
ncreased  bicarbonate  and  dissolved  CO2.12 Although  acute
ncreases  in  PaCO2 and  H+  stimulate  ventilation,  as  baseline
aCO2 and  bicarbonate  levels  increase,13 further  increases
esult  in  respiratory  depression,  obtundation,  and  agonal
reathing  as  nasally  insufﬂated  air  leaks  out  of  the  mouth.
ikewise,  nasal  bi-level  PAP  is  also  less  effective  in  the
cute  setting  for  patients  receiving  supplemental  O2 for  lung
isease14--16 as  it  is  for  patients  receiving  heavy  sedation  or
arcotics.6
A  limitation  of  this  study  is  that  for  cases  2  and  8,  base-
ine  EtCO2 was  compared  with  PaCO2 during  O2 delivery.
ince  people  with  NMD  generally  have  normal  lung  tis-
ue  diffusion,  EtCO2 differs  minimally  from  PaCO2.  Reports
uggest  that  EtCO2 is  117 to  2--6  mm  Hg  less  than  PaCO2 (R-
alue  of  0.94--0.98)  unless  cardiac  output  and  lung  perfusion
ressures  are  decreased.18,19 Thus,  EtCO2 can  be  conve-
iently  used  for  home  sleep  monitoring,  whereas  PaCO2
ecessitates  indwelling  arterial  lines.
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Administering  O2 and  pressure-preset  bi-level  PAP  rather
than  volume-preset  NVS  precludes  the  use  of  active  lung  vol-
ume  recruitment  (air  stacking),20 which  along  with  failure  to
use  MIE,  prevented  sufﬁcient  cough  ﬂows  for  cases  1  and  4  to
avoid  pneumonia  and  intubation.  Cases  5  and  8  demonstrate
that  even  chronic  low-ﬂow  O2 therapy  (2  L/min)  can  result
in  CO2 narcosis.  Although  CTMV  dependent,  decanulation  to
CNVS  permitted  case  5  to  wean  back  to  nocturnal-only  NVS.
This  effect  of  weaning  from  CTMV  to  part-time  NVS  is  espe-
cially  pronounced  when  hyperventilated,  hypocapnic  CTMV
users  are  decanulated  to  NVS.21,22 Cases  1,  4,  5,  6,  and  8
were  all  successfully  extubated  or  decanulated  to  CNVS  and
MIE  in  ambient  air  despite  having  no  ventilator-free  breath-
ing  ability.
Conclusion
For  only  2  of  316  intubated  patients  were  CO2 levels  known
to  the  clinician  administering  O2 and  intubating  the  patient.
Physicians  need  to  obtain  CO2 analyses  before  administer-
ing  O2 to  NMD  patients  with  respiratory  distress  and  to
attempt  to  resolve  the  problem  by  using  CNVS  and  MIE.
The  O2 should  only  be  administered  if  CNVS  and  MIE  have
failed  to  normalize  ambient  air  O2 sat,  in  which  case  they
should  be  prepared  to  intubate.  Whereas  hypercapnic  lung
disease  patients  have  poor  prognoses  with  a  5-year  survival
of  30%  for  patients  whose  forced  expiratory  volume-one  sec-
ond  (FEV1)  is  less  than  750  mL,23 patients  with  NMD  have
been  reported  to  have  survived  20  to  over  60  years  using
CNVS.20 Thus,  O2 therapy  should  not  be  used  as  a  substitute
for  NVS  and  MIE  to  maintain  normal  O2 sat  (>94%).  Avoid-
ing  O2 also  permits  oximetry  to  gauge  hypercapnia,  airway
secretion  encumbrance,  and  intrinsic  lung  disease  as  well  as
the  effectiveness  of  NVS  and  MIE  in  treating  them.24
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